Toronto, ON (PRWEB) September 12, 2022 In this webinar, the featured speakers will be discussing the impact of the new ICH E14 and S7B revisions and how
/PRNewswire/ Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials,.
Collaboration will improve patient experience and study efficiency through wearable technology – while capturing a wider range of activity and sleep data.
Collaboration combines Clario s eCOA innovations with Cogstate s expertise in neuroscience research to yield highest quality endpoints Partnership expansion.
ESG Report highlights substantial progress in Diversity, Equity, Inclusion and Environmental actions aimed at creating a more just and sustainable world First.